Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
09996 Peijia Medical Limited
6.230
-0.210-3.26%
YOY
Do not show
Hide blank lines
(Q6)2022/06/30(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31
Assets
Current assets
Inventory
80.69% 84.06M 161.45% 66.11M 202.86% 46.52M 126.51% 25.29M
Accounts receivable
-- 64.85M -- -- -- -- -- --
Advance deposits and other receivables
7.8% 56.96M 11.83% 64.14M 67.42% 52.84M 113.72% 57.36M
Cash and equivalents
-37.58% 1.89B -6.59% 2.3B 16.53% 3.02B 387.12% 2.46B
Financial assets at fair value-current assets
-- -- -- -- -83.23% 35.21M -78.25% 3.26M
Total current assets
-33.73% 2.09B -4.63% 2.43B 10.75% 3.16B 356.23% 2.54B
Non-current assets
Property, plant and equipment
88.77% 213.8M 69.48% 151.21M -- 113.26M -- 89.22M
Investment property
-6.92% 7.28M -6.69% 7.55M -64.22% 7.82M -63.98% 8.09M
Advance payment
-60.11% 3.19M 555.53% 52.61M 184.94% 8M 132.3% 8.03M
Long-term receivables
-- 12.64M -- -- -- -- -- --
Fixed time deposit-non-current assets
-- 170M -- -- -- -- -- --
Financial assets at fair value-non-current assets
-- 236.24M -- 224.42M -- -- -- --
Intangible assets
90.16% 399.47M 29.38% 276.5M -3.3% 210.08M -2.55% 213.72M
Special items of non-current assets
-8.61% 21.7M 37.95% 25.01M -70.83% 23.74M -76.34% 18.13M
Total non-current assets
193.28% 1.06B 118.66% 737.31M 12.25% 362.9M 4.76% 337.19M
Total assets
-10.34% 3.16B 9.8% 3.16B 10.9% 3.52B 227.61% 2.88B
Liabilities
Current liabilities
Accounts payable
191.71% 112.21M 233.3% 115.16M -4.36% 38.47M -27.47% 34.55M
Bank loans and overdrafts
-- 56M -- -- -- -- -- --
Financial lease liabilities-current liabilities
-37.36% 1.93M -61.17% 3.55M 143.9% 3.08M 640.39% 9.13M
Special items of current liabilities
-68.89% 457K -- -- 136.94% 1.47M -46% 709K
Total current liabilities
296.62% 170.59M 167.42% 118.71M 2.16% 43.01M -11.55% 44.39M
Net current assets
-38.29% 1.92B -7.68% 2.31B 10.88% 3.12B 392.61% 2.5B
Total assets less current liabilities
-14.13% 2.99B 7.34% 3.04B 11.02% 3.48B 242.08% 2.84B
Non-current liabilities
Long-term bank loan
-- 9.03M -- -- -- -- -- --
Long-term accounts payable
-- 6.25M -- -- -- -- -- --
Financial lease liabilities-non-current liabilities
-26.51% 2.61M -- 4.08M 625.92% 3.56M -- --
Deferred tax liability
0% 20.32M 0% 20.32M 0% 20.32M 0% 20.32M
Deferred income-non-current liabilities
-61.22% 1.22M -58.16% 1.37M -10.6% 3.15M -8.55% 3.28M
Total non-current liabilities
45.89% 39.43M 9.2% 25.78M 10.37% 27.02M -98.3% 23.6M
Total liabilities
199.88% 210.02M 112.49% 144.48M 5.18% 70.04M -95.27% 67.99M
Total assets less total liabilities
-14.6% 2.95B 7.32% 3.02B 11.03% 3.45B 603.98% 2.81B
Total equity and non-current liabilities
-14.13% 2.99B 7.34% 3.04B 11.02% 3.48B 242.08% 2.84B
Equity
Share capital
0.73% 6.37B 15% 6.34B 14.5% 6.32B 6828.8% 5.51B
Other reserves
-5.61% 60.1M 27.07% 69.14M 68.19% 63.68M 54.14% 54.41M
Retained profit
-16.9% -3.4B -21.03% -3.31B -18.56% -2.91B -305.72% -2.73B
Special items of shareholders' rights and interests
-192.63% -84.51M -265.6% -84.55M -- -28.88M -- -23.13M
Shareholders' Equity
-14.6% 2.95B 7.32% 3.02B 11.03% 3.45B 603.98% 2.81B
Total equity
-14.6% 2.95B 7.32% 3.02B 11.03% 3.45B 603.98% 2.81B
Total equity and total liabilities
-10.34% 3.16B 9.8% 3.16B 10.9% 3.52B 227.61% 2.88B
Currency Unit
CNYCNYCNYCNY
Accounting Standards
IASIASIASIAS
Audit Opinions
--Unqualified Opinion--Unqualified Opinion
Auditor
--PricewaterhouseCoopers--PricewaterhouseCoopers

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Peijia Medical Ltd is a Chinese holding company mainly engaged in the research and development of medical devices for interventional surgery. Through its subsidiary, the company mainly operates two business units. Transcatheter valvular therapy business department is mainly engaged in the research and development of transcatheter valvular therapy medical devices. The nerve intervention business department is engaged in the research and development of medical instruments for nerve intervention surgery. The company's main products under research include TaurusOne, TaurusElite and TaurusNXT. The company mainly does business in China.
CEO: Yi Zhang
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...